Erasca Investor Deadline Set for Class Action Lawsuit
Investors who lost over $100,000 in Erasca, Inc. securities between January 14, 2025, and April 26, 2026, have until August 10, 2026, to apply to be lead plaintiff in a class action lawsuit.
NEW ORLEANS, July 24, 2026 – A securities class action lawsuit has been filed against Erasca, Inc. (NasdaqGS: ERAS), and shareholder information service ClaimsFiler is reminding investors with significant losses of an upcoming deadline to participate. Specifically, investors who purchased or acquired Erasca securities between January 14, 2025, and April 26, 2026, and suffered losses exceeding $100,000, must file lead plaintiff applications by August 10, 2026.
The lawsuit alleges that Erasca and certain executives violated federal securities laws by failing to disclose material information. The core of the complaint centers on the preclinical data for the company's ERAS-0015 product, a molecular glue intended for RAS-mutated solid tumors. The suit claims this data was presented with improper comparisons to competitor Revolution Medicines, Inc., thus potentially infringing on patent and trade secret protections.
According to the lawsuit, defendants lacked a reasonable basis for positive statements made about ERAS-0015. The action is pending in the United States District Court for the Southern District of California, case number Cheng v. Erasca, Inc., No. 26-cv-03481. Investors seeking more information or legal options are advised to contact Kahn Swick & Foti, LLC.
ClaimsFiler operates as a free service to inform retail investors about securities class action settlements and deadlines. The service provides access to case information and assists investors in understanding their potential claims.